Australian Statistics on Medicines 2011

Table 1 - Cardiovascular System

CARDIOVASCULAR SYSTEM

C01 - CARDIAC THERAPY
C02 - ANTIHYPERTENSIVES
C03 - DIURETICS
C04 - PERIPHERAL VASODILATORS
C05 - VASOPROTECTIVES
C07 - BETA BLOCKING AGENTS
C08 - CALCIUM CHANNEL BLOCKERS
C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
C10 - LIPID MODIFYING AGENTS PLAIN

C01 - CARDIAC THERAPY
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM CARDIAC THERAPY CARDIAC GLYCOSIDES DIGITALIS GLYCOSIDES
C01AA05	DIGOXIN
	P	1322N	Tablet 250ug	0.25	MG	121,736	1,300,571
	P	2605D	Tablet 62.5ug	0.25	MG	286,148	2,971,072
	P	3164M	Oral solution for children 50ug per mL, 100mL	0.25	MG	466	12,693
ANTIARRHYTHMICS CLASS I AND III
ANTIARRHYTHMICS CLASS IA
C01BA03	DISOPYRAMIDE
	P	2923W	Capsule 100mg	0.40	GM	4,378	128,978
	P	2924X	Capsule 150mg	0.40	GM	2,698	127,971
ANTIARRHYTHMICS CLASS IB
C01BB01	LIGNOCAINE HYDROCHLORIDE
	P	2875H	Injection 100mg in 5mL	3.00	GM	1,548	67,254
	P	2876J	Infusion 500mg in 5mL	3.00	GM	220	7,351
	P	3474W	Injection 100mg in 5mL	3.00	GM	9,151	341,011
ANTIARRHYTHMICS CLASS IC
C01BC04	FLECAINIDE ACETATE
	P	1088G	Tablet 50mg 60	0.20	GM	92,661	3,572,359
	P	1090J	Tablet 100mg	0.20	GM	129,724	5,975,876
ANTIARRHYTHMICS CLASS III
C01BD01	AMIODARONE HYDROCHLORIDE
	A	21775	Tablet 100mg 30	0.20	GM	114	-
	A	21776	Tablet 200mg 30	0.20	GM	4,864	-
	P	2343H	Tablet 200mg	0.20	GM	257,904	5,431,022
	P	2344J	Tablet 100mg	0.20	GM	119,601	1,755,282
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
ADRENERGIC AGENTS
C01CA24	ADRENALINE
	P	1016L	Injection 1mg in 1mL (1 in 1,000)	0.50	MG	1,659	33,185
	P	3408J	I.M. injection 150ug in 0.3mL single dose auto-injector	0.50	MG	395	78,715
	P	3409K	I.M. injection 300ug in 0.3mL single dose auto-injector	0.50	MG	579	110,394
	P	3451P	Injection 1mg in 1mL (1 in 1,000)	0.50	MG	22,684	461,078
	P	8697R	I.M. injection 150mg in 0.3mL syringe	0.50	MG	22,186	4,330,695
	P	8698T	I.M. injection 300mg in 0.3mL syringe	0.50	MG	51,503	9,092,004
VASODILATORS USED IN CARDIAC DISEASES
ORGANIC NITRATES
C01DA02	GLYCERYL TRINITRATE
	P	1459T	Tablets 600ug 100	2.50	MG	71,622	1,028,367
	P	1515R	Td pad releasing approx. 5mg per 24 hours	5.00	MG	177,563	4,835,297
	P	1516T	Td pad releasing approx. 10mg per 24 hours	5.00	MG	91,015	3,075,387
	P	3475X	Buccal/sublingual spray (pump pack) 400ug per dose	2.50	MG	21,071	424,159
	P	8010N	Td patch releasing approx. 5mg per 24 hours	5.00	MG	91,145	2,487,973
	P	8011P	Td patch releasing approx. 10mg per 24 hours	5.00	MG	43,895	1,484,499
VASODILATORS USED IN CARDIAC DISEASES
	P	8026K	Td patch releasing approx. 1mg per 24 hours	5.00	MG	19,018	643,769
	P	8027L	Td patch releasing approx. 5mg per 24 hours	5.00	MG	6,829	186,392
	P	8028M	Td patch releasing approx. 10mg per 24 hours	5.00	MG	5,135	173,746
	P	8119H	Td patch releasing approx. 15mg per 24 hours	5.00	MG	3,382	115,860
	P	8171C	Buccal/sublingual spray (pump pack) 400ug per dose	2.50	MG	315,748	6,299,001
C01DA08	ISOSORBIDE DINITRATE
	P	2587E	Tablet 10mg	60.00	MG	9,601	107,063
	P	2588F	Sublingual tablet 5mg	20.00	MG	6,153	87,246
C01DA14	ISOSORBIDE MONONITRATE
	P	1558B	Tablets sustained release 60mg 30	40.00	MG	675,389	8,565,007
	P	8273K	Tablets sustained release 120mg 30	40.00	MG	251,126	5,291,262
OTHER VASODILATORS USED IN CARDIAC DISEASES
C01DX16	NICORANDIL
	P	8228C	Tablet 10mg	40.00	MG	168,717	4,083,946
	P	8229D	Tablet 20mg	40.00	MG	78,668	2,475,409
OTHER CARDIAC PREPARATIONS
OTHER CARDIAC PREPARATIONS
C01EB17	IVABRADINE
	A	19957	Tablets 5mg 56	10.00	MG	20,833	-
	A	19958	Tablets 7.5mg 56	10.00	MG	6,754	-

C02 - ANTIHYPERTENSIVES
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM ANTIHYPERTENSIVES ANTIADRENERGIC AGENTS CENTRALLY ACTING METHYLDOPA
C02AB01	METHYLDOPA
	P	1629R	Tablet 250mg	1.00	GM	156,857	2,182,266
IMIDAZOLINE RECEPTOR AGONISTS
C02AC01	CLONIDINE
	A	12786	Ampoule 150ug/mL 5	0.45	MG	112	-
	P	3141H	Tablet 150ug	0.45	MG	31,653	1,207,725
	P	3145M	Tablet 100ug	0.45	MG	113,406	3,275,392
C02AC05	MOXONIDINE
	P	9019Q	Tablet 200mg 30	0.30	MG	252,848	5,210,259
	P	9020R	Tablet 400mg 30	0.30	MG	218,021	6,389,842
ANTIADRENERGIC AGENTS PERIPHERALLY ACTING
ALPHA - ADRENOCEPTOR BLOCKING AGENTS
C02CA01	PRAZOSIN HYDROCHLORIDE
	P	1478T	Tablet 5mg (base)	5.00	MG	120,631	2,497,394
	P	1479W	Tablet 1mg (base)	5.00	MG	321,518	3,943,937
	P	1480X	Tablet 2mg (base)	5.00	MG	183,534	2,691,752
ARTERIOLAR SMOOTH MUSCLE AGENTS ACTING ON
HYDRAZINOPHTHALAZINE DERIVATIVES
C02DB02	HYDRALAZINE HYDROCHLORIDE
	P	1639G	Tablet 50mg	0.10	GM	29,349	501,795
	P	1640H	Tablet 25mg	0.10	GM	35,243	535,508
PYRIMIDINE DERIVATIVES
C02DC01	MINOXIDIL
	P	2313R	Tablet 10mg	20.00	MG	5,085	281,628
OTHER ANTIHYPERTENSIVES
OTHER ANTHIYPERTENSIVES
C02KX02	AMBRISENTAN
	P	9648T	Tablet 5mg 30	7.50	MG	201	820,365
	P	9649W	Tablet 10mg 30	7.50	MG	365	1,489,625
C02KX01	BOSENTAN
	P	6429J	Tablet 62.5mg (base) 60	0.25	MG	152	608,151
	P	6430K	Tablet 125mg (base) 60	0.25	MG	2,526	10,307,832

C03 - DIURETICS
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM DIURETICS LOW-CEILING DIURETICS THIAZIDES THIAZIDES PLAIN
C03AA03	HYDROCHLOROTHIAZIDE
	P	1484D	Tablet 25mg	25.00	MG	92,463	1,948,482
LOW-CEILING DIURETICS EXCL. THIAZIDES
SULFONAMIDES PLAIN
C03BA04	CHLORTHALIDONE
	P	1585K	Tablet 25mg	25.00	MG	28,581	438,924
C03BA11	INDAPAMIDE
	P	2436F	Tablet 2.5mg 90	2.50	MG	143,202	2,425,013
	P	8532C	Tablet 1.5mg (sustained release) 90	2.50	MG	344,322	6,430,822
HIGH-CEILING DIURETICS
SULFONAMIDES PLAIN
C03CA02	BUMETANIDE
	A	17855	Tablet 1mg	1.00	MG	7,677	-
C03CA01	FRUSEMIDE
	P	2411X	Oral solution 10mg per mL 30mL	40.00	MG	3,111	57,231
	P	2412Y	Tablet 40mg	40.00	MG	1,231,675	10,696,447
	P	2413B	Injection 20mg in 2mL	40.00	MG	7,798	88,345
	P	2414C	Tablet 20mg	40.00	MG	312,359	2,763,092
	P	2415D	Tablet 500mg	40.00	MG	13,878	245,282
	P	3466K	Injection 20mg in 2mL	40.00	MG	9,876	101,552
ARYLOXYACETIC ACID DERIVATIVES
C03CC01	ETHACRYNIC ACID
	P	8748K	Tablet 25mg	50.00	MG	2,551	471,898
POTASSIUM-SPARING AGENTS
ALDOSTERONE ANTAGONISTS
C03DA04	EPLERENONE
	P	8879H	Tablet 25mg 30	50.00	MG	13,538	1,548,505
	P	8880J	Tablet 50mg 30	50.00	MG	2,809	329,441
C03DA01	SPIRONOLACTONE
	P	2339D	Tablet 25mg	75.00	MG	343,328	4,171,369
	P	2340E	Tablet 100mg	75.00	MG	63,506	1,840,818
OTHER POTASSIUM-SPARING AGENTS
C03DB01	AMILORIDE HYDROCHLORIDE
	P	3109P	Tablet 5mg	10.00	MG	19,553	152,429
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
C03EA01	HYDROCHLOROTHIAZIDE with AMILORIDE HYDROCHLORIDE
	P	1486F	Tablet 50mg-5mg	-	-	123,513	1,660,571
C03EA01	HYDROCHLOROTHIAZIDE with TRIAMTERENE
	P	1280J	Tablet 25mg-50mg 100	-	-	26,932	346,548

C04 - PERIPHERAL VASODILATORS
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM PERIPHERAL VASODILATORS PERIPHERAL VASODILATORS PURINE DERIVATIVES
C04AD03	OXPENTIFYLLINE
	A	17632	Tablet 400mg 50	1.00	GM	2,716	-
OTHER PERIPHERAL VASODILATORS
C04AX02	PHENOXYBENZAMINE HYDROCHLORIDE
	P	1862B	Capsule 10mg 30	30.00	MG	178	13,368
	P	9286R	Capsule 10mg 100	30.00	MG	1,685	2,159,563

C05 - VASOPROTECTIVES
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM VASOPROTECTIVES AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE CORTICOSTEROIDS
C05AA01	HYDROCORTISONE with CINCHOCAINE HYDROCHLORIDE
	P	4036K	Ointment 5mg-5mg per g (0.5%-0.5%) 30g	-	-	6,990	159,061
C05AA01	HYDROCORTISONE, CINCHOCAINE HYDROCHLORIDE
	A	14345	Ointment 5mg-5mg-10mg per g (0.5%-0.5%-1%)	-	-	4,573	-
	P	4038M	Suppositories 5mg-5mg 12	-	-	7,550	171,000
C05AA01	HYDROCORTISONE, LIGNOCAINE BASE, ALUMINIUM SUBACETATE and ZINC OXIDE
	A	14653	Ointment 2.5mg-50mg-35mg-180mg per g	-	-	2,604	-
C05AA04	PREDNISOLONE HEXANOATE, CINCHOCAINE HYDROCHLORIDE and CLEMIZOLE UNDECYLENATE
	A	14656	Ointment 1.9mg-5mg-10mg per g (0.16-0.5%-1%)	-	-	16,820	-
	A	14657	Ointment 1.9mg-5mg-10mg per g (0.195-0.5%-1%)	-	-	16,010	-
	A	14658	Suppositories 1.3mg-1mg-5mg 12	-	-	10,581	-
LOCAL ANESTHETICS
C05AD03	ADRENALINE EPHEDRINE BENZOCAINE ZINC OXIDE
	A	13134	Ointment 50g 1	-	-	3,303	-
MUSCLE RELAXANTS
C05AE01	GLYCERYL TRINITRATE
	A	16349	Ointment 0.2% 30g 1	-	-	1,244	-
	A	20786	Ointment 0.2% 15g 1	-	-	447	-
OTHER AGENTS FOR TREATMENT HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AX04	ZINC OXIDE
	P	4039N	Compound ointment 50g	-	-	2,519	36,367
	P	4040P	Compound suppositories, 12	-	-	1,400	20,874
ANTIVARICOSE THERAPY
HEPARINS OR HEPARINOIDS FOR TOPICAL USE
C05BA01	HEPARINOID
	A	12829	Cream 0.3%40g 1	-	-	848	-
	A	13774	Cream 0.3% 20g 1	-	-	1,095	-
CAPILLARY STABILIZING AGENTS
BIOFLAVONOIDS
C05CA02	HYDROXYETHYLRUTOSIDES
	A	16101	Capsule 250mg 100	-	-	508	-

C07 - BETA BLOCKING AGENTS
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS PLAIN BETA BLOCKING AGENTS PLAIN NON-SELECTIVE
C07AA02	OXPRENOLOL HYDROCHLORIDE
	P	2942W	Tablet 20mg	0.16	GM	1,679	19,854
	P	2961W	Tablet 40mg	0.16	GM	8,462	133,621
C07AA03	PINDOLOL
	P	3062E	Tablet 5mg	15.00	MG	15,485	174,246
	P	3065H	Tablet 15mg	15.00	MG	17,191	233,293
C07AA05	PROPRANOLOL HYDROCHLORIDE
	P	2565B	Tablet 10mg	0.16	GM	157,217	1,605,164
	P	2566C	Tablet 40mg	0.16	GM	301,035	3,190,267
	P	2899N	Tablet 160mg	0.16	GM	25,588	284,389
C07AA07	SOTALOL HYDROCHLORIDE
	P	2043M	Tablet 160mg	0.16	GM	95,155	2,458,512
	P	8398B	Tablet 80mg 60	0.16	GM	388,242	5,996,520
BETA BLOCKING AGENTS PLAIN SELECTIVE
C07AB03	ATENOLOL
	P	1081X	Tablet 50mg	0.08	GM	3,867,794	38,650,746
C07AB07	BISOPROLOL
	P	8604W	Tablet 2.5mg	10.00	MG	240,843	11,957,373
	P	8605X	Tablet 5mg	10.00	MG	231,087	13,890,184
	P	8606Y	Tablet 10mg	10.00	MG	194,890	13,902,969
C07AB02	METOPROLOL SUCCINATE
	P	8732N	Tablet 23.75mg (controlled release) 15	150.00	MG	10,217	332,283
	P	8733P	Tablet 47.5mg (controlled release) 30	150.00	MG	41,964	3,134,857
	P	8734Q	Tablet 95mg (controlled release) 30	150.00	MG	41,009	3,749,505
	P	8735R	Tablet 190mg (controlled release) 30	150.00	MG	31,247	3,446,363
C07AB02	METOPROLOL TARTRATE
	P	1324Q	Tablet 50mg	150.00	MG	1,375,891	14,574,845
	P	1325R	Tablet 100mg	150.00	MG	434,014	5,136,930
C07AB12	NEBIVOLOL
	P	9310B	Tablet 1.25mg (as hydrochloride), 28	5.00	MG	5,286	174,739
	P	9311C	Tablet 5mg (as hydrochloride) 28	5.00	MG	14,082	873,666
	P	9312D	Tablet 10mg (as hydrochloride) 28	5.00	MG	6,891	469,386
	P	9316H	Tablet 1.25mg (as hydrochloride) 28	5.00	MG	4,672	197,151
ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS
C07AG02	CARVEDILOL
	A	21656	Tablet 12.5mg 60	37.50	MG	128	-
	P	8255L	Tablet 3.125mg 30	37.50	MG	27,596	532,271
	P	8256M	Tablet 6.25mg	37.50	MG	115,505	5,262,477
	P	8257N	Tablet 12.5mg	37.50	MG	142,831	7,752,629
	P	8258P	Tablet 25mg	37.50	MG	258,276	17,571,323
C07AG01	LABETALOL HYDROCHLORIDE
	P	1566K	Tablet 100mg	0.60	GM	19,499	297,330
BETA BLOCKING AGENTS PLAIN
	P	1567L	Tablet 200mg	0.60	GM	21,000	467,972

C08 - CALCIUM CHANNEL BLOCKERS
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS DIHYDROPYRIDINE DERIVATIVES
C08CA01	AMLODIPINE
	P	1343Q	Tablet 5mg (base) maleate salt 30	5.00	MG	231,616	3,751,969
	P	1345T	Tablet 10mg (base) maleate salt 30	5.00	MG	169,513	3,996,696
	P	2751T	Tablet 5mg (base) besylate salt 3 0	5.00	MG	1,429,246	23,266,376
	P	2752W	Tablet 10mg (base) besylate salt 30	5.00	MG	1,108,109	26,241,413
C08CA02	FELODIPINE
	P	2361G	Tablet 2.5mg (extended release)	5.00	MG	178,805	2,269,700
	P	2366M	Tablet 5mg (extended release)	5.00	MG	421,515	6,515,374
	P	2367N	Tablet 10mg (extended release)	5.00	MG	512,676	12,150,398
C08CA13	LERCANIPIDINE
	P	8534E	Tablet 10mg 30	10.00	MG	1,177,917	18,281,391
	P	8679T	Tablet 20mg 30	10.00	MG	1,039,096	22,203,753
C08CA05	NIFEDIPINE
	P	1694E	Tablet 10mg 60	30.00	MG	35,448	542,043
	P	1695F	Tablet 20mg 60	30.00	MG	30,095	533,962
	P	1906H	Tablet 30mg (controlled release) 30	30.00	MG	301,024	5,616,714
	P	1907J	Tablet 60mg (controlled release) 30	30.00	MG	290,823	6,519,440
	P	8610E	Tablet 20mg (controlled release) 30	30.00	MG	119,439	2,130,646
	P	8938K	Tablet 20mg (controlled release) 30	30.00	MG	4,443	100,021
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
PHENYLALKYLAMINE DERIVATIVES
C08DA01	VERAPAMIL HYDROCHLORIDE
	P	1241H	Tablet 240mg (sustained release)	0.24	GM	534,899	8,670,086
	P	1248Q	Tablet 40mg	0.24	GM	32,706	368,192
	P	1250T	Tablet 80mg	0.24	GM	29,262	438,530
	P	1253Y	Tablet 160mg	0.24	GM	11,609	210,300
	P	1254B	Tablet 120mg	0.24	GM	6,171	116,304
	P	2206D	Capsule 160mg (sustained release)	0.24	GM	55,835	701,034
	P	2207E	Capsule 240mg (sustained release)	0.24	GM	106,508	1,723,544
	P	2208F	Capsule 180mg (sustained release)	0.24	GM	213,254	2,940,710
	P	3494X	Injection 5mg in 2mL	0.24	GM	3,150	38,982
BENZOTHIAZEPINE DERIVATIVES
C08DB01	DILTIAZEM HYDROCHLORIDE
	P	1312C	Capsule 180mg controlled delivery	0.24	GM	464,949	7,807,306
	P	1313D	Capsule 240mg controlled delivery	0.24	GM	438,848	8,961,909
	P	1335G	Tablet 60mg	0.24	GM	50,193	792,553
	P	8480H	Capsule 360mg controlled delivery 30	0.24	GM	300,890	7,433,076
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C08EX02	PERHEXILINE MALEATE
	P	1822X	Tablet 100mg	0.20	GM	30,025	1,881,938

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN CONVERTING ENZYME BLOCKERS
C09AA01	CAPTOPRIL
	P	1147J	Tablet 12.5mg	50.00	MG	4,894	78,869
	P	1148K	Tablet 25mg	50.00	MG	15,805	325,204
	P	1149L	Tablet 50mg	50.00	MG	25,739	900,493
	P	8760C	Oral solution 5mg per mL 95mL	50.00	MG	1,180	142,329
C09AA02	ENALAPRIL MALEATE
	P	1368B	Tablet 10mg	10.00	MG	141,373	2,475,339
	P	1369C	Tablet 20mg	10.00	MG	271,790	6,087,737
	P	1370D	Tablet 5mg	10.00	MG	63,609	829,912
C09AA09	FOSINOPRIL
	P	1182F	Tablet 10mg 30	15.00	MG	103,778	1,595,274
	P	1183G	Tablet 20mg	15.00	MG	197,569	4,143,110
C09AA03	LISINOPRIL
	P	2456G	Tablet 5mg 30	10.00	MG	86,774	1,201,903
	P	2457H	Tablet 10mg 30	10.00	MG	165,265	2,915,320
	P	2458J	Tablet 20mg 30	10.00	MG	307,237	6,629,154
C09AA04	PERINDOPRIL
	P	3050M	Tablet 2mg (erbumine) 30	4.00	MG	401,360	4,926,661
	P	3051N	Tablet 4mg (erbumine) 30	4.00	MG	752,035	13,085,090
	P	8704D	Tablet 8mg (erbumine) 30	4.00	MG	664,291	15,442,002
	P	9006B	Tablet 2.5mg (arginine) 30	4.00	MG	664,891	8,156,917
	P	9007C	Tablet 5mg (arginine) 30	4.00	MG	1,503,712	26,274,992
	P	9008D	Tablet 10mg (arginine) 30	4.00	MG	1,452,903	33,913,829
C09AA06	QUINAPRIL
	P	1968N	Tablet 5mg (as hydrochloride) 30	15.00	MG	30,421	415,694
	P	1969P	Tablet 10mg (as hydrochloride) 30	15.00	MG	85,159	1,436,308
	P	1970Q	Tablet 20mg (as hydrochloride) 30	15.00	MG	185,703	3,839,635
C09AA05	RAMIPRIL
	P	1316G	Tablet 10mg 30	2.50	MG	190,488	4,332,095
	P	1944H	Capsule 1.25mg 28	2.50	MG	163,028	1,851,158
	P	1945J	Capsule 2.5mg 28	2.50	MG	521,801	7,118,129
	P	1946K	Capsule 5.0mg 28	2.50	MG	954,040	14,993,941
	P	8470T	Capsule 10mg 30	2.50	MG	1,430,872	32,292,099
	P	8668F	Pack 7 Tabs 2.5mg 21 tabs 5mg and 10 caps 10mg	2.50	MG	985	20,985
	P	9120B	Capsule 1.25mg 30	2.50	MG	7,271	82,291
	P	9121C	Capsule 2.5mg 30	2.50	MG	28,146	371,431
	P	9122D	Capsule 5.0mg 30	2.50	MG	36,640	564,961
C09AA10	TRANDOLAPRIL
	P	2791X	Capsule 500ug	2.00	MG	19,490	179,041
	P	2792Y	Capsule 1mg	2.00	MG	60,800	832,380
	P	2793B	Capsule 2mg	2.00	MG	134,510	2,085,062
	P	8758Y	Capsule 4mg 28	2.00	MG	146,861	3,392,489
ACE INHIBITORS, COMBINATIONS
ACE INHIBITORS, COMBINATIONS
ANGIOTENSIN-CONVERTING ENZYME BLOCKERS AND DIURETICS
C09BA02	ENALAPRIL with HYDROCHLOROTHIAZIDE
	P	8477E	Tablet 20mg-6mg	-	-	124,585	3,511,520
C09BA09	FOSINOPRIL with HYDROCHLOROTHIAZIDE
	P	8400D	Tablet 10mg-12.5mg	-	-	55,107	1,179,601
	P	8401E	Tablet 20mg-12.5mg	-	-	343,701	9,825,743
C09BA04	PERINDOPRIL with INDAPAMIDE
	P	2190G	Tablet 2.5mg (arginine)-0.625mg 30	-	-	47,004	758,766
	P	2845R	Tablet 5mg (arginine)-1.25mg 30	-	-	1,165,611	33,816,555
	P	8449Q	Tablet 4mg (erbumine)-1.25mg 30	-	-	450,325	12,748,542
C09BA06	QUINAPRIL with HYDROCHLOROTHIAZIDE
	P	8589C	Tablet 10mg(base) / 12.5mg 30	-	-	15,476	295,264
	P	8590D	Tablet 20mg(base) / 12.5mg 30	-	-	83,617	1,799,529
ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS
C09BB02	ENALAPRIL and LERCANIDIPINE
	P	9144G	Tablet 10mg-10mg 30	-	-	44,158	1,159,876
	P	9145H	Tablet 10mg-20mg 30	-	-	97,471	2,767,349
C09BB04	PERINDOPRIL and AMLODIPINE
	P	9346X	Tablet 5mg-5mg 30	-	-	121,175	3,291,098
	P	9347Y	Tablet 5mg-10mg 30	-	-	35,158	1,213,937
	P	9348B	Tablet 10mg-5mg 30	-	-	203,867	6,724,555
	P	9349C	Tablet 10mg-10mg 30	-	-	182,132	7,343,525
C09BB05	RAMIPRIL and FELODIPINE
	P	2626F	Tablet 2.5mg-2.5mg 30	-	-	9,356	187,922
	P	2629J	Tablet 5mg-5mg 30	-	-	74,820	1,991,509
C09BB10	TRANDOLAPRIL and VERAPAMIL
	P	2857J	Tablet 4mg-240mg (sustained release) 28	-	-	60,809	1,925,171
	P	9387C	Tablet 2mg-180mg (sustained release) 28	-	-	12,105	266,404
ANGIOTENSIN II ANTAGONISTS
ANGIOTENSIN II ANTAGONISTS PLAIN
C09CA06	CANDESARTAN
	P	8295N	Tablet 4mg 30	8.00	MG	311,357	5,520,702
	P	8296P	Tablet 8mg 30	8.00	MG	865,083	18,177,091
	P	8297Q	Tablet 16mg 30	8.00	MG	1,057,118	30,761,877
	P	8889W	Tablet 32mg 30	8.00	MG	588,116	27,485,015
	P	8997M	Tablet 8mg 30	8.00	MG	6,588	152,202
	P	8998N	Tablet 16mg 30	8.00	MG	8,647	280,538
	P	8999P	Tablet 32mg 30	8.00	MG	4,543	223,861
C09CA02	EPROSARTAN
	P	8397Y	Tablet 400mg (base) 56	0.60	GM	21,270	606,560
	P	8447N	Tablet 600mg (base) 28	0.60	GM	66,653	2,045,606
	P	8951D	Tablet 400mg (base) 56	0.60	GM	671	20,891
ANGIOTENSIN II ANTAGONISTS
C09CA04	IRBESARTAN
	P	8246B	Tablet 75mg	150.00	MG	589,293	12,093,515
	P	8247C	Tablet 150mg	150.00	MG	1,643,422	40,408,002
	P	8248D	Tablet 300mg	150.00	MG	1,894,898	57,458,272
C09CA01	LOSARTAN
	A	16073	Tablet 50mg 30	0.05	GM	4,591	-
	P	8203R	Tablet 50mg	50.00	MG	131	3,511
C09CA08	OLMESARTAN MEDOXOMIL
	P	2147B	Tablet 20mg 30	20.00	MG	289,623	7,250,896
	P	2148C	Tablet 40mg 30	20.00	MG	249,874	7,626,762
C09CA07	TELMISARTAN
	P	8355R	Tablet 40mg	40.00	MG	1,313,692	28,510,929
	P	8356T	Tablet 80mg	40.00	MG	1,271,322	36,971,467
C09CA03	VALSARTAN
	P	9368C	Tablet 40mg 28	80.00	MG	3,980	64,417
	P	9369D	Tablet 80mg 28	80.00	MG	53,517	1,079,558
	P	9370E	Tablet 160mg 28	80.00	MG	36,684	885,277
	P	9371F	Tablet 320mg 28	80.00	MG	12,919	369,595
ANGIOTENSIN II ANTAGONISTS COMBINATIONS
ANGIOTENSIN II ANTAGONISTS AND DIURETICS
C09DA06	CANDESARTAN with HYDROCHLOROTHIAZIDE
	P	8504N	Tablet 16mg-12.5mg 30	-	-	932,420	29,120,255
	P	9314F	Tablet 32mg-12.5mg 30	-	-	218,425	10,594,131
	P	9315G	Tablet 32mg-25mg 30	-	-	105,414	5,321,860
C09DA02	EPROSARTAN with HYDROCHLOROTHIAZIDE
	P	8624X	Tablet 600mg (base) -12.5mg 28	-	-	79,493	2,560,424
C09DA04	IRBESARTAN with HYDROCHLOROTHIAZIDE
	P	2136K	Tablet 300mg-25mg 30	-	-	524,488	18,137,704
	P	8404H	Tablet 150mg-12.5mg 30	-	-	664,956	17,748,081
	P	8405J	Tablet 300mg-12.5mg 30	-	-	2,108,569	68,284,412
C09DA08	OLMESARTAN with HYDROCHLOROTHIAZIDE
	P	2161R	Tablet 20mg 12.5mg 30	-	-	70,200	1,904,165
	P	2166B	Tablet 40mg 12.5mg 30	-	-	165,015	5,312,000
	P	2170F	Tablet 40mg 25mg 30	-	-	132,820	4,572,480
C09DA07	TELMISARTAN with HYDROCHLOROTHIAZIDE
	P	8622T	Tablet 40mg-12.5mg 28	-	-	275,599	6,529,240
	P	8623W	Tablet 80mg-12.5mg 28	-	-	986,523	30,554,632
	P	9381R	Tablet 80mg-25mg 28	-	-	219,125	7,238,734
C09DA03	VALSARTAN with HYDROCHLOROTHIAZIDE
	P	9372G	Tablet 80mg-12.5mg 28	-	-	8,286	183,297
	P	9373H	Tablet 160mg-12.5mg 28	-	-	14,800	384,375
	P	9374J	Tablet 160mg-25mg 28	-	-	7,069	198,195
	P	9481B	Tablet 320mg-12.5mg 28	-	-	7,534	230,850
ANGIOTENSIN II ANTAGONISTS COMBINATIONS
	P	9482C	Tablet 320mg-25mg 28	-	-	6,610	216,147
ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS
C09DB01	AMLODIPINE and VALSARTAN
	P	5459H	Tablet 5mg as (besylate)-320mg 28	-	-	13,077	493,166
	P	5460J	Tablet 10mg as (besylate)-320mg 28	-	-	18,595	819,565
	P	9375K	Tablet 5mg as (besylate)-80mg 28	-	-	62,061	1,817,322
	P	9376L	Tablet 5mg as (besylate)-160mg 28	-	-	122,506	4,063,429
	P	9377M	Tablet 10mg as (besylate)-160mg 28	-	-	135,013	5,384,050
C09DB02	OLMESARTAN with AMLODIPINE
	P	5292M	Tablet containing olmesartan medoxomil 20mg with amlodipine 5mg (as besylate)	-	-	18,591	643,570
	P	5293N	Tablet containing olmesartan medoxomil 40mg with amlodipine 5mg (as besylate)	-	-	33,662	1,334,845
	P	5294P	Tablet containing olmesartan medoxomil 40mg with amlodipine 10mg (as besylate)	-	-	26,730	1,234,590
C09DB04	TELMISARTAN and AMLODIPINE
	P	8978M	Tablet 40mg-5mg (as besylate) 28	-	-	11,143	342,843
	P	8979N	Tablet 40mg-10mg (as besylate) 28	-	-	2,415	90,728
	P	8980P	Tablet 80mg-5mg (as besylate) 28	-	-	24,894	945,666
	P	8981Q	Tablet 80mg-10mg (as besylate) 28	-	-	13,973	619,208
ANGIOTENSIN II ANTAGONISTS OTHER COMBINATIONS
C09DX01	AMLODIPINE with VALSARTAN and HYDROCHLOROTHIAZIDE
	P	5285E	Tablet 5mg (as besylate)-160mg-12.5mg	-	-	32,022	1,124,529
	P	5286F	Tablet 5mg (as besylate)-160mg-25mg	-	-	9,123	339,084
	P	5287G	Tablet 10mg (as besylate)-160mg-12.5mg	-	-	28,295	1,181,947
	P	5288H	Tablet 10mg (as besylate)-160mg-25mg	-	-	11,954	520,789
	P	5289J	Tablet 10mg (as besylate)-320mg-25mg	-	-	23,186	1,104,845

C10 - LIPID MODIFYING AGENTS PLAIN
				2011
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS PLAIN LIPID MODIFYING AGENTS PLAIN HMG REDUCTASE INHIBITORS
C10AA05	ATORVASTATIN
	P	8213G	Tablet 10mg (as calcium) 30	20.00	MG	1,618,265	68,969,500
	P	8214H	Tablet 20mg (as calcium) 30	20.00	MG	3,612,371	209,258,444
	P	8215J	Tablet 40mg (as calcium) 30	20.00	MG	4,022,296	317,721,039
	P	8521L	Tablet 80mg (as calcium) 30	20.00	MG	1,466,799	161,477,124
	P	9230T	Tablet 10mg (as calcium) 30	20.00	MG	57,541	2,453,519
	P	9231W	Tablet 20mg (as calcium) 30	20.00	MG	129,380	7,501,427
	P	9232X	Tablet 40mg (as calcium) 30	20.00	MG	149,959	11,861,390
	P	9233Y	Tablet 80mg (as calcium) 30	20.00	MG	64,033	7,051,151
C10AA04	FLUVASTATIN
	P	2863Q	Tablet 80mg (as sodium) (prolonged release) 28	60.00	MG	21,972	997,815
	P	8023G	Capsule 20mg (as sodium) 28	60.00	MG	22,565	575,671
	P	8024H	Capsule 40mg (as sodium) 28	60.00	MG	32,294	989,328
	P	9234B	Capsule 20mg (as sodium) 28	60.00	MG	912	23,267
	P	9235C	Capsule 40mg (as sodium) 28	60.00	MG	1,355	43,337
	P	9236D	Capsule 80mg (as sodium) 28	60.00	MG	1,216	55,261
C10AA03	PRAVASTATIN
	P	2833D	Tablet 10mg 30	30.00	MG	74,530	1,548,514
	P	2834E	Tablet 20mg 30	30.00	MG	275,766	8,087,139
	P	8197K	Tablet 40mg 30	30.00	MG	582,615	24,433,981
	P	8829Q	Tablet 80mg 30	30.00	MG	127,986	7,536,160
	P	9237E	Tablet 10mg 30	30.00	MG	3,198	66,499
	P	9238F	Tablet 20mg 30	30.00	MG	10,835	317,851
	P	9239G	Tablet 40mg 30	30.00	MG	20,778	869,750
	P	9240H	Tablet 80mg 30	30.00	MG	7,482	440,495
C10AA07	ROSUVASTATIN
	P	3402C	Tablet 5mg (as calcium) 30	10.00	MG	33,628	1,517,306
	P	3403D	Tablet 10mg (as calcium) 30	10.00	MG	66,962	4,127,460
	P	3404E	Tablet 20mg (as calcium) 30	10.00	MG	37,640	3,201,555
	P	3405F	Tablet 40mg (as calcium) 30	10.00	MG	19,526	2,316,372
	P	9042X	Tablet 5mg (as calcium) 30	10.00	MG	1,103,734	49,868,015
	P	9043Y	Tablet 10mg (as calcium) 30	10.00	MG	3,095,837	191,151,147
	P	9044B	Tablet 20mg (as calcium) 30	10.00	MG	1,526,231	130,028,318
	P	9045C	Tablet 40mg (as calcium) 30	10.00	MG	724,079	86,088,483
C10AA01	SIMVASTATIN
	P	2011W	Tablet 10mg	30.00	MG	428,380	10,337,801
	P	2012X	Tablet 20mg	30.00	MG	1,357,650	43,330,446
	P	2013Y	Tablet 5mg	30.00	MG	23,501	451,659
	P	8173E	Tablet 40mg	30.00	MG	1,882,972	80,665,715
	P	8313M	Tablet 80mg	30.00	MG	517,303	29,434,311
	P	9241J	Tablet 5mg 30	30.00	MG	879	16,918
	P	9242K	Tablet 10mg 30	30.00	MG	15,403	371,716
LIPID MODIFYING AGENTS PLAIN
	P	9243L	Tablet 20mg 30	30.00	MG	48,869	1,558,246
	P	9244M	Tablet 40mg 30	30.00	MG	69,883	2,992,237
	P	9245N	Tablet 80mg 30	30.00	MG	24,993	1,421,790
FIBRATES
C10AB05	FENOFIBRATE
	P	9022W	Tablet 48mg 60	0.20	GM	48,371	1,449,448
	P	9023X	Tablet 145mg 30	0.20	GM	629,046	26,221,745
	P	9246P	Tablet 48mg 60	0.20	GM	3,286	98,436
	P	9247Q	Tablet 145mg 30	0.20	GM	26,218	1,093,519
C10AB04	GEMFIBROZIL
	P	1453L	Tablet 600mg	1.20	GM	165,466	4,732,962
	P	9248R	Tablet 600mg 60	1.20	GM	5,081	145,353
BILE ACID SEQUESTRANTS
C10AC02	COLESTIPOL HYDROCHLORIDE
	P	1224K	Sachets 5g 120	20.00	GM	940	79,881
C10AC01	COLESTYRAMINE
	P	2967E	Sachets 4.7g (equiv to 4g cholestyramine)	14.00	GM	33,525	2,362,895
	P	9249T	Sachets 4.7g (equiv to 4g cholestyramine) 50, 2	14.00	GM	2,290	162,588
NICOTINIC ACID AND DERIVATIVES
C10AD02	NICOTINIC ACID
	A	19191	Tablet 250mg	2.00	GM	4,508	-
OTHER LIPID MODIFYING AGENTS
C10AX09	EZETIMIBE
	P	8757X	Tablet 10mg 30	10.00	MG	1,057,245	75,175,089
C10AX06	FISH OIL
	A	21434	Capsule 1000mg 28	-	-	1,281	-
LIPID MODIFYING AGENTS COMBINATIONS
HMG COA REDUCTASE INHIBITORS IN COMBINATION WITH OTHER LIPID MOD AGENTS
C10BA02	SIMVASTATIN and EZETIMIBE
	P	8881K	Tablet 40mg-10mg 30	-	-	375,579	40,478,393
	P	8882L	Tablet 80mg-10mg 30	-	-	354,566	43,932,207
	P	9483D	Tablet 10mg-10mg 30	-	-	24,271	2,154,379
	P	9484E	Tablet 10mg-20mg 30	-	-	32,448	3,130,878
HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONS
C10BX03	ATORVASTATIN and AMLODIPINE
	P	9049G	Tablet 10mg (base) 5mg (base) 30	-	-	88,719	4,537,185
	P	9050H	Tablet 20mg (base) 5mg (base) 30	-	-	199,380	13,417,836
	P	9051J	Tablet 40mg (base) 5mg (base) 30	-	-	212,957	18,817,326
	P	9052K	Tablet 80mg (base) 5mg (base) 30	-	-	75,333	9,004,578
	P	9053L	Tablet 10mg (base) 10mg (base) 30	-	-	66,380	3,831,127
	P	9054M	Tablet 20mg (base) 10mg (base) 30	-	-	177,581	13,206,886
	P	9055N	Tablet 40mg (base) 10mg (base) 30	-	-	233,066	22,240,079
	P	9056P	Tablet 80mg (base) 10mg (base) 30	-	-	97,811	12,378,857

Australian Statistics on Medicines 2011

Table 1 - Cardiovascular System

Department of Health and Aged Care

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry